Lu Fu

849 total citations
39 papers, 545 citations indexed

About

Lu Fu is a scholar working on Physiology, Molecular Biology and Oncology. According to data from OpenAlex, Lu Fu has authored 39 papers receiving a total of 545 indexed citations (citations by other indexed papers that have themselves been cited), including 11 papers in Physiology, 9 papers in Molecular Biology and 6 papers in Oncology. Recurrent topics in Lu Fu's work include Alzheimer's disease research and treatments (9 papers), Tryptophan and brain disorders (4 papers) and Ferroptosis and cancer prognosis (3 papers). Lu Fu is often cited by papers focused on Alzheimer's disease research and treatments (9 papers), Tryptophan and brain disorders (4 papers) and Ferroptosis and cancer prognosis (3 papers). Lu Fu collaborates with scholars based in China, United States and Philippines. Lu Fu's co-authors include Luquan Ren, Hongwei Zhao, Hu Huang, Han Qu, Jianping Li, Zunqiang Fan, Hui Wu, Xianghui Yu, Tao Cui and Jiaxin Wu and has published in prestigious journals such as Journal of the American College of Cardiology, Scientific Reports and Journal of Computational Physics.

In The Last Decade

Lu Fu

37 papers receiving 531 citations

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name h Career Trend Papers Cites
Lu Fu China 13 159 128 118 108 66 39 545
Dongdong Wang China 13 58 0.4× 133 1.0× 13 0.1× 74 0.7× 102 1.5× 34 885
Hengchuan Liu China 14 142 0.9× 239 1.9× 32 0.3× 187 1.7× 22 0.3× 38 751
Chih‐Lung Shen Taiwan 14 53 0.3× 276 2.2× 307 2.6× 322 3.0× 10 0.2× 64 846
Shaowei Wu China 14 18 0.1× 56 0.4× 34 0.3× 88 0.8× 42 0.6× 30 427
Hiroshi Fujioka Japan 16 67 0.4× 153 1.2× 55 0.5× 38 0.4× 53 0.8× 72 726
Shao Zhao Singapore 9 171 1.1× 107 0.8× 130 1.1× 58 0.5× 46 0.7× 12 836
Barbara Hargrave United States 17 55 0.3× 166 1.3× 17 0.1× 89 0.8× 293 4.4× 32 861
Anfeng Zhao China 13 77 0.5× 174 1.4× 85 0.7× 246 2.3× 81 1.2× 22 579
Yong‐Joon Choi Japan 10 45 0.3× 144 1.1× 13 0.1× 56 0.5× 73 1.1× 66 371

Countries citing papers authored by Lu Fu

Since Specialization
Citations

This map shows the geographic impact of Lu Fu's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Lu Fu with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Lu Fu more than expected).

Fields of papers citing papers by Lu Fu

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Lu Fu. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Lu Fu. The network helps show where Lu Fu may publish in the future.

Co-authorship network of co-authors of Lu Fu

This figure shows the co-authorship network connecting the top 25 collaborators of Lu Fu. A scholar is included among the top collaborators of Lu Fu based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Lu Fu. Lu Fu is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

20 of 20 papers shown
1.
2.
Fu, Lu, et al.. (2026). Smoothed particle-mesh hydrodynamics (SPMH) for fluid-structure interactions involving thin structures. Journal of Computational Physics. 550. 114650–114650.
3.
Li, Ruicen, et al.. (2025). A Risk Prediction Model for the Development of Rheumatoid Arthritis, Sjögren's Syndrome, Systemic Sclerosis in Patients With Systemic Lupus Erythematosus: Multicenter Approaches. International Journal of Rheumatic Diseases. 28(2). e70156–e70156. 1 indexed citations
4.
Wang, Jue, Linlin Zhang, Lu Fu, & Zheng Pang. (2025). Kaempferol Mitigates Pseudomonas aeruginosa-Induced Acute Lung Inflammation Through Suppressing GSK3β/JNK/c-Jun Signaling Pathway and NF-κB Activation. Pharmaceuticals. 18(3). 322–322. 1 indexed citations
5.
Fu, Lu, Chen Zhang, Shuguang Wang, et al.. (2025). Targeting Ferroptosis With Natural Products to Treat Diabetes and Its Complications: Opportunities and Challenges. Phytotherapy Research. 39(12). 5695–5716. 1 indexed citations
6.
Zhang, Dongdong, Shu Jiang, Wan Yue, et al.. (2025). Prediction of a novel synthetic peptide vaccine against tuberculosis and validation of its immunogenicity. International Immunopharmacology. 153. 114531–114531.
7.
Liang, Ting, Fang Hu, Lu Fu, et al.. (2025). Single‐Cell RNA Sequencing Identifies MMP11 + Cancer‐Associated Fibroblasts as Drivers of Angiogenesis and Bladder Cancer Progression. Advanced Science. 12(32). e02774–e02774. 2 indexed citations
8.
Qi, Xiaoyi, Sha Liu, Li Liu, et al.. (2023). Sanguinarine inhibits melanoma invasion and migration by targeting the FAK/PI3K/AKT/mTOR signalling pathway. Pharmaceutical Biology. 61(1). 696–709. 15 indexed citations
9.
Xu, Wang‐Dong, Linchong Su, Lu Fu, et al.. (2022). IL-38, a potential therapeutic agent for lupus, inhibits lupus progression. Inflammation Research. 71(7-8). 963–975. 8 indexed citations
10.
11.
12.
Gong, Zheng, Wen Li, Huimin Bu, et al.. (2021). Impact of COVID-19 pandemic on the professional intention of medical and related students. BMC Medical Education. 21(1). 484–484. 11 indexed citations
13.
Sun, Yao, Yongqing Guo, Xuejian Feng, et al.. (2020). The behavioural and neuropathologic sexual dimorphism and absence of MIP-3α in tau P301S mouse model of Alzheimer’s disease. Journal of Neuroinflammation. 17(1). 72–72. 77 indexed citations
14.
Fu, Lu, Yao Sun, Yongqing Guo, et al.. (2017). Comparison of neurotoxicity of different aggregated forms of Aβ40, Aβ42 and Aβ43 in cell cultures. Journal of Peptide Science. 23(3). 245–251. 30 indexed citations
15.
Fu, Lu, Yingnan Li, Bin Yu, et al.. (2015). Norovirus P particle: An excellent vaccine platform for antibody production against Alzheimer’s disease. Immunology Letters. 168(1). 22–30. 17 indexed citations
16.
Wang, Yu, et al.. (2014). Serum Parathyroid Hormone as a Potential Novel Biomarker of Coronary Heart Disease. Genetic Testing and Molecular Biomarkers. 18(10). 670–674. 3 indexed citations
17.
Liu, Ximing, Lu Fu, Wenwen Dai, et al.. (2014). Design of transparent film-forming hydrogels of tolterodine and their effects on stratum corneum. International Journal of Pharmaceutics. 471(1-2). 322–331. 19 indexed citations
18.
Fu, Lu, et al.. (2013). The Relationship Between Diastolic Pressure and Coronary Collateral Circulation in Patients With Stable Angina Pectoris and Chronic Total Occlusion. American Journal of Hypertension. 26(5). 630–635. 14 indexed citations
19.
Li, Yuanshi, Lu Fu, Qianping Gao, & Dan Ma. (2010). Valsartan alleviates atherosclerotic lesions in pulmonary arteries of rabbits via an endothelium-dependent mechanism. Acta Cardiologica. 65(1). 23–29. 6 indexed citations
20.
Fu, Lu. (2000). Effect and Mechanism of Erythropoietin on Amino Acid in Hemodialysis Patients. 1 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact

Breakdown of academic impact, for papers by Dongdong Wang Breakdown of academic impact, for papers by Hengchuan Liu Breakdown of academic impact, for papers by Chih‐Lung Shen Breakdown of academic impact, for papers by Shaowei Wu Breakdown of academic impact, for papers by Hiroshi Fujioka Breakdown of academic impact, for papers by Shao Zhao Breakdown of academic impact, for papers by Barbara Hargrave Breakdown of academic impact, for papers by Anfeng Zhao Breakdown of academic impact, for papers by Yong‐Joon Choi
Rankless by CCL
2026